Novus Therapeutics, Inc.
19900 MacArthur Blvd., Suite 550
Irvine, CA 92612
(949) 238-8090
June 14, 2019
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
| Attn: | Sonia Bednarowski |
| Re: | Novus Therapeutics, Inc. |
Registration Statement on Form S-1
Filed June 7, 2019
File No. 333-232011
Ladies and Gentlemen:
Pursuant to Rules 460 and 461 promulgated under the Securities Act of 1933, as amended, Novus Therapeutics, Inc., a Delaware corporation (the “Company”), hereby respectfully requests that the effective time of the above referenced Registration Statement on Form S-1 filed by the Company (the “Registration Statement”) be accelerated to 4:01 p.m., Eastern Daylight Time, on June 17, 2019 or as soon thereafter as practicable.
[Signature page follows]
| Very truly yours, | ||
| Novus Therapeutics, Inc. | ||
| By: | /s/ Gregory J. Flesher | |
| Name: | Gregory J. Flesher | |
| Title: | Chief Executive Officer | |
| cc: | Ryan A. Murr, Gibson, Dunn & Crutcher LLP |